Analysts Estimates and Ratings Altimmune, Inc.(NASDAQ:ALT): Kinross Gold Corporation(NYSE:KGC)

0
4

Altimmune, Inc. (ALT) will report its next earnings on Aug 13 BMO. The company reported the earnings of $-2.34/Share in the last quarter where the estimated EPS by analysts was $-3.6/share. The difference between the expected and actual EPS was $1.26/share, which represents an Earnings surprise of 35%.

Many analysts are providing their Estimated Earnings analysis for Altimmune, Inc. and for the current quarter 0 analysts have projected that the stock could give an Average Earnings estimate of $0/share. These analysts have also projected a Low Estimate of $0/share and a High Estimate of $0/share.

In case of Revenue Estimates, 1 analysts have provided their consensus Average Revenue Estimates for Altimmune, Inc. as 2.59 Million. According to these analysts, the Low Revenue Estimate for Altimmune, Inc. is 3.52 Million and the High Revenue Estimate is 3.52 Million. The company had Year Ago Sales of 2.81 Million.

Some buy side analysts are also providing their Analysis on Altimmune, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

Altimmune, Inc. closed its last trading session at $2.66 with the loss of -7.89%. The Market Capitalization of the company stands at 32.02 Million. The Company has 52-week high of $36.25 and 52-week low of $1.70. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 3.09% where SMA50 and SMA200 are -2.95% and -29.26% respectively. The Company Touched its 52-Week High on 09/20/18 and 52-Week Low on 12/24/18.

The Relative Volume of the company is 1.44 and Average Volume (3 months) is 410.36 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -71%. The Return on Equity (ROE) value stands at -87.3%. While it’s Return on Investment (ROI) value is -75.8%.

While looking at the Stock’s Performance, Altimmune, Inc. currently shows a Weekly Performance of 3.81%, where Monthly Performance is 4.7%, Quarterly performance is -22.71%, 6 Months performance is -12.5% and yearly performance percentage is -82.39%. Year to Date performance value (YTD perf) value is 18.93%. The Stock currently has a Weekly Volatility of 7.29% and Monthly Volatility of 5.80%.

Kinross Gold Corporation (KGC) will report its next earnings on Jul 31 AMC. The company reported the earnings of $0.07/Share in the last quarter where the estimated EPS by analysts was $0.02/share. The difference between the expected and actual EPS was $0.05/share, which represents an Earnings surprise of 250%.

Many analysts are providing their Estimated Earnings analysis for Kinross Gold Corporation and for the current quarter 13 analysts have projected that the stock could give an Average Earnings estimate of $0.02/share. These analysts have also projected a Low Estimate of $0/share and a High Estimate of $0.06/share.

In case of Revenue Estimates, 6 analysts have provided their consensus Average Revenue Estimates for Kinross Gold Corporation as 813.95 Million. According to these analysts, the Low Revenue Estimate for Kinross Gold Corporation is 797.65 Million and the High Revenue Estimate is 831 Million. The company had Year Ago Sales of 775 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for KGC to be -33.3%. They are projecting Next Quarter growth of 175%. For the next 5 years, Kinross Gold Corporation is expecting Growth of 35.83% per annum, whereas in the past 5 years the growth was 50% per annum.

Some buy side analysts are also providing their Analysis on Kinross Gold Corporation, where 5 analysts have rated the stock as Strong buy, 4 analysts have given a Buy signal, 5 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Kinross Gold Corporation might touch $5.52 high while the Average Price Target and Low price Target is $4.21 and $3 respectively.

Kinross Gold Corporation closed its last trading session at $3.92 with the gain of 5.1%. The Market Capitalization of the company stands at 5.16 Billion. The Company has 52-week high of $4.01 and 52-week low of $2.38. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 10.2% where SMA50 and SMA200 are 20.48% and 29.74% respectively. The Company Touched its 52-Week High on 07/10/19 and 52-Week Low on 11/14/18.

The Relative Volume of the company is 1.45 and Average Volume (3 months) is 10.12 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 24.09.

The company shows its Return on Assets (ROA) value of -0.8%. The Return on Equity (ROE) value stands at -1.4%. While it’s Return on Investment (ROI) value is 1%.

While looking at the Stock’s Performance, Kinross Gold Corporation currently shows a Weekly Performance of 7.85%, where Monthly Performance is 20.12%, Quarterly performance is 14.44%, 6 Months performance is 27.95% and yearly performance percentage is 6.19%. Year to Date performance value (YTD perf) value is 27.16%. The Stock currently has a Weekly Volatility of 3.62% and Monthly Volatility of 3.81%.

SHARE